Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

Clinical trial NCT06868290 · RECRUITING

Trial details

NCT number: NCT06868290
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ANCA Associated Vasculitis (AAV)

Start date: 2025-03-13
Primary completion: 2029-06-07
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.